Dawn of a New Era of Oral Anticoagulation
Excerpt
Ever since their introduction in the middle of the 20th century, vitamin K antagonists (VKAs) have been used in the treatment and prevention of thromboembolic diseases, especially for venous thromboembolism and stroke prevention in atrial fibrillation (AF) [...]
Share and Cite
Steffel, J. Dawn of a New Era of Oral Anticoagulation. Cardiovasc. Med. 2012, 15, 143. https://doi.org/10.4414/cvm.2012.01669
Steffel J. Dawn of a New Era of Oral Anticoagulation. Cardiovascular Medicine. 2012; 15(5):143. https://doi.org/10.4414/cvm.2012.01669
Chicago/Turabian StyleSteffel, Jan. 2012. "Dawn of a New Era of Oral Anticoagulation" Cardiovascular Medicine 15, no. 5: 143. https://doi.org/10.4414/cvm.2012.01669
APA StyleSteffel, J. (2012). Dawn of a New Era of Oral Anticoagulation. Cardiovascular Medicine, 15(5), 143. https://doi.org/10.4414/cvm.2012.01669